Oncologic Disorders Cancer Flashcards

1
Q

CANCER

A
  • Disease process that begins when a cell is transformed by genetic
    mutation of cellular DNA. Cancer can involve any organ system.
  • Terms:
  • Benign cells: not cancerous; may grow but unable to spread
  • Malignant cancer: cells or processes that are characteristic of cancer
  • Metastasis: Abnormal cells invade surrounding tissue and gain access to
    lymph and blood vessels carrying them to other areas of the body
  • Strong familial factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PRECISION MEDICINE DEVELOPMENT

A
  • Possible due to recent development of biologic databases (e.g.,
    human genome sequencing)
  • Technologic advances that can identify unique characteristics of
    individual persons (e.g., genomics, cellular assay tests)
  • Computer-driven systems that can mine and analyze datasets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

EPIDEMIOLOGY

A
  • Approximately 600k persons lost to cancer annually
  • Most occur in older adults
  • Men slightly higher incidence (Black men highest)
  • Lung, prostate, colorectal
  • Women (again, Black women are at a slightly higher risk)
  • Lung, breast, colorectal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MALIGNANT PROCESS

A
  • Cell proliferation:
  • Genetically altered cells clone and proliferate abnormally
  • Evade normal intra/extracellular processes such as growth
    regulating and immune system defenses
  • Abnormalities in cell signaling processes lead to cancer
    development
  • Ultimately metastasis occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS

A
  • Cell characteristics
  • Mode of growth
  • Rate of growth
  • Metastasis
  • General effects
  • Tissue destruction
  • Ability to cause death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CHARACTERISTICS OF BENIGN AND
MALIGNANT NEOPLASMS (TABLE 12-1)

A

BENIGN
* Grows by expansion, no
infiltration of adjacent cells
* Slow growth
* No metastasis
* Localized effects
* Rare tissue damage
* Death rare

MALIGNANT
* Grows at periphery, invades
surrounding tissues
* Variable growth rate
* Uses blood and lymph channels
to invade other areas
* Generalized effects
* Frequent tissue damage
* Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CARCINOGENESIS (MALIGNANT
TRANSFORMATION)

A
  • Three-step process
  • Initiation: apoptosis
  • Carcinogens cause mutations in cellular DNA. Normal cell cycle
    interrupted.
  • Promotion: initiated cells are prompted to grow and survive. tumor
    suppressor gene - preneoplastic/benign lesions
  • Progression: proliferation and differentiation; angiogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CARCINOGENIC AGENTS AND FACTORS

A
  • Viruses
  • HPV, HBV, EBV
  • Bacteria
  • H Pylori

Physical agents:
* Sunlight: cumulative exposure
* Radiation: x-ray, radon
* Chronic irritation
* Genetic, and familial factors
Diet, obesity, Red meat and alcohol

Chemical agents:
* Tobacco: combustible & smokeless
* Asbestos
* Many others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SYMPTOMS & WARNING SIGNS OF CANCER

A
  • Change in bowel or bladder habits.
  • A sore that does not heal.
  • Unusual bleeding or discharge.
  • Thickening or lump in the breast or elsewhere.
  • Indigestion or difficulty in swallowing.
  • Obvious change in a wart or mole.
  • Nagging cough or hoarseness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DIAGNOSIS OF CANCER

A
  • Physical examination
  • Imaging studies
  • CT, MRI, ( w/wo contrast) Nuclear Scan, Bone Scan, PET Scan
  • Laboratory tests of blood, urine, and other body fluids
  • BRCA1 and BRCA2
  • Exploratory/diagnostic procedures
  • Pathologic analysis (biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Biopsy:
* Needle:

  • Excisional:
  • Incisional:
A

Biopsy:
* Needle: sample suspicious masses that are easily and safely
accessible
* Excisional: small, easily accessible tumors
* Incisional: tumor mass is too large to be removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SURGICAL TREATMENT

A
  • Prophylactic surgery
  • Removal of non-vital tissues or organs that are at increased risk of
    developing cancer
  • Palliative surgery
  • Relieve symptoms, promote comfort, increase quality of life
  • Reconstructive surgery
  • s/p breast, head/neck, skin sx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RADIATION THERAPY

A
  • Used with/without chemotherapy
  • Localized therapy
  • Damages DNA within the cancer cells
  • More effective on tissues that are faster growing
  • Bone marrow, lymphatic tissue, GI tract, gonads
  • Less effective on slower growing tissues
  • Muscle, nervous system, connective tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

External Beam Radiation Therapy (EBRT)

  • Stereotactic Body Radiotherapy (SBRT)
A

External Beam Radiation Therapy (EBRT)
* Delivers tightly targeted radiation beams directed from different
angles and different planes from outside the body.
* Involves several daily treatments (fractions) over a few days to a
few weeks.
* Stereotactic Body Radiotherapy (SBRT)
* Higher doses of radiation over shorter time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Brachytherapy

A

Brachytherapy
* Placement of radioactive sources within or immediately next to the
cancer site
* Intense, highly targeted
* Seeds, beads, ribbons placed in body cavities, interstitial tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NURSING CARE OF THE PATIENT
UNDERGOING RADIATION THERAPY

A
  • Protecting caregivers during brachytherapy
  • Private room
  • Appropriate notices, dosimeter badges
  • Pregnant staff members are not assigned
  • Restrict visits by children or pregnant women
  • Limiting visits to 30 minutes/day
  • Maintain a 6-foot distance
17
Q

CHEMOTHERAPY ADMINISTRATION
* Dosage

A
  • BSA, weight, previous chemotherapy or radiation, function of
    major organ systems
  • Extravasation via vesicants
  • No peripheral veins of hand or wrist
  • PIV only for short-term chemo
  • Prolonged dosing requires central line
18
Q

CHEMOTHERAPY ADMINISTRATION
* Hypersensitivity reactions (HSRs)
*

A

Unexpected, adverse drug reactions associated with mild or
progressively worsening signs and symptoms
* Repeated exposure increases the likelihood of a reaction
* Desensitization procedures may be possible
* Premedication

19
Q

CHEMOTHERAPY TOXICITY

A
  • Gastrointestinal
  • Hematopoietic
  • Renal
  • Cardiopulmonary
  • Reproductive
  • Neurologic
  • Cognitive
  • Fatigue
20
Q

NURSING MANAGEMENT IN CHEMOTHERAPY

A
  • Assessing fluid, electrolyte status
  • Assessing cognitive status
  • Modifying risks for infection, bleeding
  • Administering chemotherapy
  • Preventing nausea and vomiting
  • Managing fatigue
  • Protecting caregivers
21
Q

HEMATOPOIETIC STEM CELL TRANSPLANTATION
(HSCT)

A
  • Used to treat several malignant and nonmalignant diseases
  • malignant myeloma, acute leukemia, and non-Hodgkin lymphoma
  • Types of HSCT
  • Allogeneic – matched donor
  • Myeloablative - high dose chemo w/ total body radiation
  • Nonmyeloablative – less aggressive combination of chemotherapy
    and/or radiation
  • Autologous – from patient
  • Syngeneic – identical twin
22
Q

GRAFT-VERSUS-HOST DISEASE (GVHD)

A
  • Major cause of morbidity and mortality in the allogeneic
    transplant population
  • Occurs when the donor lymphocytes initiate an immune
    response against the recipient’s tissues (skin, gastrointestinal
    tract, liver) during the beginning of engraftment
  • To prevent GVHD, patients receive immunosuppressant drugs
  • May be acute (within first 100 days) or chronic (occurring after
    100 days)
23
Q

NURSING MANAGEMENT IN HSCT

A
  • Implementing pre-transplantation care
  • Providing care during treatment
  • Close monitoring of VS
  • Providing post-transplantation care
  • Caring for recipients
  • Caring for donors
  • Hyperthermia
24
Q

NURSING CARE OF PATIENTS WITH CANCER: SEE CHART 12-6

A
  • Maintaining tissue integrity
  • Stomatitis
  • inflammatory process of the mouth
  • Radiation-associated impairment of skin integrity
  • radiation dermatitis
  • Alopecia
  • Often temporary unless radiation
  • Malignant skin lesions
  • foul-smelling lesions
    Promoting nutrition
  • Nutritional impairment
  • Anorexia
  • Malabsorption
  • Cancer-related anorexia-cachexia syndrome
  • Relieving pain
  • Decreasing fatigue
  • Improving body self image
25
Q

MONITORING AND MANAGING POTENTIAL
COMPLICATIONS

A
  • Infection
  • Cancer and associated medications can alter bodies immune
    response
  • Usual signs of infection may not be obvious (temperature)
  • WBC function is often impaired in patients with cancer
  • Neutropenia – ANC
  • Septic shock – monitor for early warning signs
  • Bleeding, hemorrhage
  • Thrombocytopenia due to suppressed bone marrow
  • Platelet destruction